Log in
A+ A A-

New schizophrenia drug candidates entering prep for first-in-human testing

New drug candidates for schizophrenia are now entering the stage of preparation for first-in-human clinical testing

 

The Vanderbilt Center for Neuroscience Drug Discovery announced Dec. 15 that new drug candidates for schizophrenia generated from its ongoing collaboration with Janssen Pharmaceuticals, Nev., are now entering the stage of preparation for first-in-human clinical testing.

“This is a major step forward in the evaluation of this approach as a potential treatment for major psychiatric diseases. It could lead to a fundamental advance in the treatment of schizophrenia,” said P. Jeffrey Conn, co-director of the Vanderbilt Center for Neuroscience Drug Discovery.

Subscribe to this RSS feed

39°F

New York

Fair

Humidity: 20%

Wind: 7 mph

  • 5 Apr 2016 43°F 29°F
  • 6 Apr 2016 49°F 44°F